Home › Medulloblastoma › Illinois › Chicago
Medulloblastoma clinical trials in Chicago, IL
3 studies for Medulloblastoma are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
RecruitingPhase 3
- University of Illinois, Chicago
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
RecruitingPhase 2
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
RecruitingPhase 2
- Advocate Aurora Research Institute, Chicago
Medulloblastoma trials in other cities
- Washington, DC9 studies
- St. Louis, MO6 studies
- New York City, NY4 studies
- Seattle, WA4 studies
- Philadelphia, PA4 studies
- Houston, TX4 studies
- Durham, NC4 studies
- Miami, FL4 studies
- Tampa, FL4 studies
- Mountain View, CA3 studies
- Memphis, TN3 studies
- San Diego, CA3 studies
Other studies in Chicago
- Non-Small Cell Lung Cancer62 studies
- Breast Cancer58 studies
- Cancer (all types)52 studies
- Prostate Cancer45 studies
- Metastatic Cancer45 studies
- Lung Cancer41 studies
- Obesity41 studies
- Ovarian Cancer37 studies
- Stroke35 studies
- Heart Failure32 studies
- Colorectal Cancer32 studies
- Overweight27 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.